Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 252, Issue 6, 2014, Pages 1001-1008

  Kang, Hae Min ^a,b   Lee, Sung Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b International St Mary's Hospital   (South Korea)

Author keywords

Beh et disease; Beh et uveitis; Fluorescein angiography; Retinal vasculitis

Indexed keywords

AZATHIOPRINE; METHOTREXATE; STEROID; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BEHCET DISEASE; CAPILLARY LEAK SYNDROME; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE SEVERITY; EYE EXAMINATION; FLUORESCEIN ANGIOGRAPHY SCORING SYSTEM; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MEDICAL RECORD REVIEW; OPTIC DISC HYPERFLUORESCENCE; OPTIC DISK; PRIORITY JOURNAL; RETINA MACULA EDEMA; RETINA VASCULITIS; RETROSPECTIVE STUDY; SCORING SYSTEM; STEROID THERAPY; VISUAL ACUITY; VISUAL IMPAIRMENT; BEHCET SYNDROME; BLOOD RETINA BARRIER; CAPILLARY PERMEABILITY; FEMALE; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINAL VASCULITIS; YOUNG ADULT;

ADULT; BEHCET SYNDROME; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETINAL VASCULITIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; YOUNG ADULT;

EID: 84902239603     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-014-2637-z     Document Type: Article

References (27)

1. Deuter CM, Kötter I, Wallace GR, Murray PI, Stübiger N, Zierhut M (2008) Behçet's disease: ocular effects and treatment. Prog Retin Eye Res 27:111-136
2. George RK, Chan C, Whitcup SM, Nussenblatt RB (1997) Ocular immunopathology of Behçet's disease. Surv Ophthalmol 42:157-162
3. Chajek T, Fainaru M (1975) Behçet's disease. Report of 41 cases and a review of the literature. Medicine 54:179-196
4. Kontogianis V, Powell RJ (2000) Behçet's disease. Postgrad Med J 76:629-637
5. Wong RC, Ellis CN, Diaz LA (1984) Behçet's disease. Int J Dermatol 23:25-32
6. Llopis MD, Cervera M, Menezo JL (1990) Cyclosporin A treatment of Behçet's disease: a long term study. Curr Eye Res 9:17-23 (Pubitemid 20295595)
7. Evereklioglu C (2005) Current concepts in the etiology and treatment of Behçet's disease. Surv Ophthalmol 50:297-350
8. Atmaca LS (1989) Fundus changes associated with Behçet's disease. Graefes's Arch Clin Exp Ophthalmol 227:340-344
9. Atmaca LS, Batioglu F (1994) The efficacy of cyclosporine A in the treatment of Behçet's disease. Ophthalmic Surg 25:321-327 (Pubitemid 24149976)
10. Ozdal PC, Ortaç S, Taşkintuna I, Taşkintuna I, Firat E (2001) Posterior segment involvement in ocular Behçet's disease. Eur J Ophthalmol 12:424-431
11. Altenburg A, Papoustis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiology and clinical manifestations of Adamantiades-Behçet's disease in Germany-current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49-64
12. Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdoǧan H, Serdaroǧlu S, Ersanli M, Ulkü BY, Müftüoǧlu AU (1984) Influence of age of onset and patient's sex on prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 43:783-789 (Pubitemid 15190181)
13. Yazici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Behçet's syndrome. Drugs 42:796-804 (Pubitemid 21920785)
14. Ben-Ezra D, Cohen E (1986) Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 70:589-592
15. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behçet's disease: an analysis of 880 patients. Am J Ophthalmol 138:373-380 (Pubitemid 39208563)
16. Atmaca LS, Sonmez PA (2003) Fluorescein and indocyanine green angiography findings in Behçet's disease. Br J Ophthalmol 87:1466-1468 (Pubitemid 38010549)
17. Gedik S, Akova Y, Yilmaz G, Bozbeyoǧlu S (2005) Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behçet's disease. Ocular Immunol Inflamm 13:51-58 (Pubitemid 41702785)
18. Yu HG, Kim MJ, Oh FS (2009) Fluorescein angiography and visual acuity in active uveitis with Behçet's disease. Ocular Immunol Inflamm 17:41-46
19. Tugal-Tutkun I, Herbort CP, Khairallah M, The Angiography Scoring for Uveitis Working Group (ASUWOG) (2010) Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol 30:539-553
20. The International Study Group for Behçet's disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 1335:1078-1080
21. Jabs DA, Nussenblatt RB, Rosenbaum JT, The Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509-516 (Pubitemid 41224845)
22. Spitznas M (2006) Understanding fluorescein angiography. Springer, Berlin, pp 73-99
23. Nussenblatt R (2010) Uveitis: fundamentals and clinical practice, 4th edn. Elsevier, Philadelphia, pp 42-71
24. Verity DH, Vaughan RW, Madanat W, Kondeatis E, Zureikat H, Fayyad F, Kanawati CA, Ayesh I, Stanford MR, Wallace GR (1999) Factor V Leiden mutation is associated with ocular involvement in Behçet's disease. Am J Ophthalmol 128:352-356 (Pubitemid 29413233)
25. Takeuchi M, Hokama H, Tsukahara R, Kezuka T, Goto H, Sakai J, Usui M (2005) Risk and prognostic factors of poor visual outcome in Behçet's disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol 243:1147-1152 (Pubitemid 43124166)
26. Gueudry J, Wechsler B, Terrada C, Gendron G, Cassoux N, Fardeau C, Lehoang P, Piette JC, Bodaghi B (2008) Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Am J Ophthalmol 146:837-844
27. Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I (2010) Long-term remission after cessation of interferon-á treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum 62:2796-2805